At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PROF Profound Medical Corp.
Not Yet Opened 11-13 16:00:00 EST
8.17
+0.21
+2.64%
盘后8.17
+0.000.00%
16:40 EST
High8.26
Low7.95
Vol30.60K
Open8.03
D1 Closing7.96
Amplitude3.86%
Mkt Cap201.49M
Tradable Cap182.45M
Total Shares24.66M
T/O247.52K
T/O Rate0.14%
Tradable Shares22.33M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.